Drugs / allogeneic γ9δ2 T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05755854 | May 2023 → Dec 2024 | hematologic disorder | Anhui Provincial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | allogeneic γ9δ2 T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05755854 ↗ |
| Modality | Cell therapy | “allogeneic γ9δ2 T cell injection” NCT05755854 ↗ |